Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

CPIX | Cumberland Pharmaceuticals Inc.

Healthcare | Drug Manufacturers - Specialty & Generic | USA | NASD

Index	-	P/E	-	EPS (ttm)	-0.12	Insider Own	45.42%	Shs Outstand	14.37M	Perf Week	-0.53%
Market Cap	26.87M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	7.84M	Perf Month	15.43%
Income	-1.78M	PEG	-	EPS next Q	-	Inst Own	16.82%	Short Float / Ratio	0.27% / 1.06	Perf Quarter	22.62%
Sales	40.65M	P/S	0.66	EPS this Y	4.17%	Inst Trans	-9.46%	Short Interest	0.02M	Perf Half Y	-1.58%
Book/sh	2.59	P/B	0.72	EPS next Y	-	ROA	-1.96%	Target Price	8.50	Perf Year	-28.08%
Cash/sh	1.27	P/C	1.47	EPS next 5Y	30.00%	ROE	-4.66%	52W Range	1.43 - 2.91	Perf YTD	-16.89%
Dividend	-	P/FCF	2.70	EPS past 5Y	5.22%	ROI	-3.20%	52W High	-35.74%	Beta	0.23
Dividend %	-	Quick Ratio	1.21	Sales past 5Y	1.03%	Gross Margin	70.09%	52W Low	30.77%	ATR	0.13
Employees	85	Current Ratio	1.62	Sales Q/Q	5.73%	Oper. Margin	-14.68%	RSI (14)	49.95	Volatility	9.20% 7.82%
Optionable	Yes	Debt/Eq	0.51	EPS Q/Q	-	Profit Margin	-4.39%	Rel Volume	0.16	Prev Close	1.79
Shortable	Yes	LT Debt/Eq	0.50	Earnings	Aug 08 AMC	Payout	-	Avg Volume	20.07K	Price	1.87
Recom	1.00	SMA20	-2.53%	SMA50	8.15%	SMA200	-3.64%	Volume	3,190	Change	4.47%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-12-12	Reiterated	UBS	Neutral	$6.50 → $5
Feb-01-11	Reiterated	UBS	Neutral	$8 → $6.50
Dec-16-10	Downgrade	UBS	Buy → Neutral	$10 → $8
Aug-17-10	Reiterated	UBS	Buy	$11 → $10
Aug-17-10	Reiterated	Morgan Joseph	Buy	$15 → $10
Aug-17-10	Downgrade	Jefferies	Buy → Hold	$13 → $5.50
May-14-10	Reiterated	Morgan Joseph	Buy	$21 → $15

Aug-08-23 04:33PM	Cumberland: Q2 Earnings Snapshot (AP Finance)
04:05PM	Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023 (PR Newswire)
Aug-01-23 04:05PM	CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Jun-26-23 09:00AM	NEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN PEDIATRIC PATIENTS (PR Newswire)
May-31-23 05:22AM	CPIX: A Solid Stock with an Exciting Catalyst (Zacks Small Cap Research)
09:00AM	Loading…
May-23-23 09:00AM	CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS (PR Newswire)
May-15-23 09:00AM	CALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTS (PR Newswire) +9.09%
May-09-23 05:29PM	Cumberland: Q1 Earnings Snapshot (AP Finance)
04:05PM	Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update (PR Newswire)
May-02-23 04:05PM	CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Apr-17-23 09:52AM	Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Screens Well But There Might Be A Catch (Simply Wall St.)
Mar-08-23 07:19AM	Q4 2022 Cumberland Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-23 04:22PM	CUMBERLAND PHARMACEUTICALS REPORTS 17% REVENUE GROWTH FOR FULL YEAR 2022 (PR Newswire)
Feb-28-23 04:05PM	CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2022 FINANCIAL RESULTS (PR Newswire)
Nov-11-22 06:05AM	Cumberland Pharmaceuticals Third Quarter 2022 Earnings: US$0.028 loss per share (vs US$0.10 loss in 3Q 2021) (Simply Wall St.)
04:05PM	Loading…
Nov-08-22 04:05PM	Cumberland Pharmaceuticals Reports 41% Revenue Growth (PR Newswire)
Nov-01-22 09:20AM	CUMBERLAND PHARMACEUTICALS MOVES INTO NEW HEADQUARTERS AT BROADWEST (PR Newswire)
Aug-09-22 04:30PM	Edited Transcript of CPIX.OQ earnings conference call or presentation 9-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents)
04:05PM	Cumberland Pharmaceuticals Reports 14% Revenue Growth (PR Newswire)
Aug-08-22 09:25AM	CUMBERLAND PHARMACEUTICALS REPORTS 2.4M PATIENT DOSES DELIVERED, NO PRODUCT RECALLS, NO FDA ISSUES IN 2021 (PR Newswire)
Aug-02-22 04:05PM	CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
Jul-19-22 09:25AM	CUMBERLAND PHARMACEUTICALS APPOINTS MARTIN BROWN JR. TO ITS BOARD OF DIRECTORS (PR Newswire) +10.31%
May-13-22 12:27PM	Estimating The Intrinsic Value Of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) (Simply Wall St.)
May-10-22 04:05PM	Cumberland Pharmaceuticals Reports 6% Revenue Growth (PR Newswire)
May-09-22 09:15AM	Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement with Verity Pharmaceuticals to Expand Support for Sancuso® (PR Newswire) +8.71%
May-03-22 04:05PM	CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
Mar-31-22 09:20AM	TABUK AND CUMBERLAND PARTNER TO BRING INNOVATIVE ANTIBIOTIC WITH LIFE-SAVING POTENTIAL TO MIDDLE EAST (PR Newswire) +8.46%
Mar-08-22 04:05PM	CUMBERLAND PHARMACEUTICALS REPORTS 2021 FINANCIAL RESULTS & COMPANY UPDATE (PR Newswire) -8.08%
Mar-01-22 04:05PM	CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2021 FINANCIAL RESULTS (PR Newswire)
Jan-04-22 05:09PM	Cumberland Pharmaceuticals Inc. buys rights to oncology-related drug for $13.5 million (American City Business Journals)
09:15AM	Loading…
09:15AM	CUMBERLAND PHARMACEUTICALS ACQUIRES SANCUSO® FROM KYOWA KIRIN NORTH AMERICA (PR Newswire)
Dec-01-21 05:06AM	Cumberland Pharmaceuticals (NASDAQ:CPIX) shareholder returns have been favorable, earning 69% in 1 year (Simply Wall St.) -18.49%
Nov-30-21 11:02AM	OLMA Stock: The Breast Cancer Therapy News That Has Olema Pharmaceuticals Plunging Today (InvestorPlace) +128.64%
05:08AM	Cumberland Pharmaceuticals Stock Rockets After FDA Approves Labeling (Investing.com)
Nov-29-21 04:05PM	Caldolor® Now FDA Approved For Pre-Operative Administration (PR Newswire)
Nov-16-21 02:27PM	Cumberland Pharmaceuticals to move headquarters to Broadwest development (American City Business Journals)
Nov-09-21 04:05PM	Cumberland Pharmaceuticals Reports Third Quarter 2021 Financial Results & Company Update (PR Newswire) +6.01%
Nov-08-21 08:25AM	3 Penny Stocks Insiders Are Buying (Benzinga) +12.69%
Nov-02-21 04:05PM	Cumberland Pharmaceuticals To Announce Third Quarter 2021 Financial Results (PR Newswire)
Oct-04-21 08:17AM	3 Penny Stocks Insiders Are Buying (Benzinga)
Sep-29-21 09:25AM	Cumberland Pharmaceuticals Launches RediTrex® Product Line For Active Rheumatoid, Juvenile Idiopathic And Severe Psoriatic Arthritis (PR Newswire)
Aug-10-21 06:15PM	Cumberland Pharmaceuticals (CPIX) Reports Break-Even Earnings for Q2 (Zacks)
04:05PM	Cumberland Pharmaceuticals Reports Second Quarter 2021 Financial Results & Company Update (PR Newswire)
Aug-03-21 04:05PM	Cumberland Pharmaceuticals To Announce Second Quarter 2021 Financial Results (PR Newswire)
03:00PM	Earnings Preview: Cumberland Pharmaceuticals (CPIX) Q2 Earnings Expected to Decline (Zacks)
Jul-26-21 09:25AM	Cumberland Pharmaceuticals Reports 2.5M Patient Doses Delivered, No Product Recalls, No FDA Issues in 2020 (PR Newswire)
Jun-22-21 09:15AM	Daqo New Energy's subsidiary Xinjiang Daqo completes its IPO Registration with China Securities Regulatory Commission (PR Newswire)
06:46AM	Zacks Industry Outlook Highlights: Xencor, Organogenesis Holdings, Cumberland Pharmaceuticals and Acer Therapeutics (Zacks)
Jun-21-21 09:20AM	Vibativ® Effectively Helps Treat Secondary Bacterial Infections In COVID-19 Patients (PR Newswire) +5.70%
08:33AM	4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness (Zacks)
Jun-18-21 11:56AM	Cumberland Pharmaceuticals, Inc. (CPIX): Are Hedge Funds Right About This Stock? (Insider Monkey)
Jun-17-21 09:40AM	United Therapeutics (UTHR) Tyvaso DPI Gets FDA's Priority Tag (Zacks)
Jun-02-21 12:45PM	Is Cumberland (CPIX) a Solid Growth Stock? 3 Reasons to Think " Yes " (Zacks)
May-19-21 03:30PM	Cumberland Pharmaceuticals Names John Hamm New Chief Financial Officer (PR Newswire)
May-11-21 04:05PM	Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update (PR Newswire)
02:30PM	Cumberland Pharmaceuticals, Inc. to Host Earnings Call (ACCESSWIRE)
May-04-21 04:05PM	Cumberland Pharmaceuticals To Announce First Quarter 2021 Financial Results (PR Newswire)
Mar-09-21 06:45PM	Cumberland Pharmaceuticals (CPIX) Beats Q4 Earnings and Revenue Estimates (Zacks)
04:26PM	Recap: Cumberland Q4 Earnings (Benzinga)
04:05PM	Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020 (PR Newswire)
01:30PM	Cumberland Pharmaceuticals, Inc. to Host Earnings Call (ACCESSWIRE)
Mar-08-21 10:08AM	Cumberland Earnings Preview (Benzinga)
Mar-02-21 04:05PM	Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2020 Financial Results (PR Newswire)
Feb-17-21 12:59AM	Is Cumberland Pharmaceuticals (NASDAQ:CPIX) A Risky Investment? (Simply Wall St.)
Nov-27-20 05:22PM	Where Do Hedge Funds Stand On Cumberland Pharmaceuticals, Inc. (CPIX)? (Insider Monkey)
Nov-17-20 11:05AM	Introducing RediTrex®, A New Methotrexate Delivery System (PR Newswire)
Nov-10-20 05:45PM	Cumberland Pharmaceuticals (CPIX) Q3 Earnings and Revenues Surpass Estimates (Zacks)
05:21PM	Recap: Cumberland Q3 Earnings (Benzinga)
04:05PM	Cumberland Pharmaceuticals Reports Third Quarter 2020 Financial Results & Company Update (PR Newswire)
02:30PM	Cumberland Pharmaceuticals, Inc. to Host Earnings Call (ACCESSWIRE)
Nov-09-20 10:28AM	Cumberland's Earnings: A Preview (Benzinga)
Nov-03-20 04:05PM	Cumberland Pharmaceuticals To Announce Third Quarter 2020 Financial Results (PR Newswire)
12:30PM	Earnings Preview: Cumberland Pharmaceuticals (CPIX) Q3 Earnings Expected to Decline (Zacks)
Sep-03-20 08:47AM	Would Shareholders Who Purchased Cumberland Pharmaceuticals' (NASDAQ:CPIX) Stock Three Years Be Happy With The Share price Today? (Simply Wall St.)
Aug-18-20 09:35AM	Newly Published Literature Supports Use Of Caldolor® For Postoperative Pain And Reduction Of Opioid Use (PR Newswire)
Aug-11-20 05:35PM	Cumberland Pharmaceuticals (CPIX) Q2 Earnings and Revenues Beat Estimates (Zacks)
05:20PM	Cumberland: Q2 Earnings Insights (Benzinga)
04:05PM	Cumberland Pharmaceuticals Reports Second Quarter 2020 Financial Results & Company Update (PR Newswire)
Aug-10-20 11:04AM	Earnings Preview: Cumberland (Benzinga)
Aug-04-20 04:05PM	Cumberland Pharmaceuticals To Announce Second Quarter 2020 Financial Results (PR Newswire)
Jul-20-20 08:35AM	Caldolor® Demonstrates Significant Reduction Of Opioid Use In Orthopedic Trauma Patients (PR Newswire)
Jun-15-20 12:00PM	All You Need to Know About Cumberland (CPIX) Rating Upgrade to Buy (Zacks) +5.36%
Jun-03-20 11:09AM	Edited Transcript of CPIX earnings conference call or presentation 18-Mar-20 8:30pm GMT (Thomson Reuters StreetEvents)
May-27-20 06:00PM	Is Cumberland Pharmaceuticals (CPIX) A Good Stock To Buy Now? (Insider Monkey) -7.63%
May-26-20 04:05PM	New Publication Reveals Real-World Usage of Vibativ® In Patients With Bacteremia Or Endocarditis (PR Newswire)
May-22-20 07:30AM	Is Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Excessively Paying Its CEO? (Simply Wall St.)
May-20-20 06:15PM	Cumberland Pharmaceuticals (CPIX) Q1 Earnings and Revenues Miss Estimates (Zacks)
04:05PM	Cumberland Pharmaceuticals Reports First Quarter 2020 Financial Results & Company Update (PR Newswire)
02:30PM	Cumberland Pharmaceuticals, Inc. to Host Earnings Call (ACCESSWIRE)
May-15-20 04:40PM	Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results (PR Newswire)
May-11-20 04:10PM	Vibativ® Sustained Potency Confirmed In Two Surveillance Studies (PR Newswire)
May-05-20 12:30PM	Analysts Estimate Cumberland Pharmaceuticals (CPIX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-28-20 09:35AM	Cumberland Pharmaceuticals Releases Inaugural Report On Its Environmental, Social And Governance (ESG) Activities (PR Newswire)
Apr-17-20 08:37AM	Summit Therapeutics (SMMT) Catches Eye: Stock Jumps 8.9% (Zacks)
Apr-16-20 08:37AM	Ampio (AMPE) Looks Good: Stock Adds 5.2% in Session (Zacks)
Apr-07-20 05:00PM	To Help Prepare for the COVID-19 Patient Surge Cumberland Pharmaceuticals Expands Availability of Vaprisol® to Treat Hyponatremia in Critical Care Units (PR Newswire)
Apr-02-20 01:23PM	LLY, OXM, AMAG, MIST and CPIX as Zacks Bull and Bear of the Day (Zacks)
Mar-31-20 05:00PM	Cumberland Pharmaceuticals Announces Initiative to Expand Availability of Caldolor® to Help Treat High Fevers Associated With Coronavirus Infections (PR Newswire)
12:43PM	Penny Stocks to Buy Using Technical Analysis for April 2020 (Investopedia)
Mar-23-20 05:00PM	Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections (PR Newswire)

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Krogulski Kenneth	Director	Dec 21	Buy	2.22	360	799	204,955	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 21	Buy	2.22	180	400	57,356	Dec 23 05:10 PM
Jones James	Director	Dec 21	Buy	2.22	88	195	26,293	Dec 23 05:11 PM
Krogulski Kenneth	Director	Dec 20	Buy	2.31	370	855	204,595	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 20	Buy	2.31	200	462	57,176	Dec 23 05:10 PM
Jones James	Director	Dec 20	Buy	2.31	121	280	26,205	Dec 23 05:11 PM
Young Caroline	Director	Dec 20	Buy	2.31	109	252	19,587	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 19	Buy	2.21	450	994	204,225	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 19	Buy	2.21	250	552	56,976	Dec 23 05:10 PM
Jones James	Director	Dec 19	Buy	2.21	70	155	26,084	Dec 23 05:11 PM
Young Caroline	Director	Dec 19	Buy	2.21	30	66	19,478	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 16	Buy	2.22	246	546	203,775	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 16	Buy	2.22	100	222	56,726	Dec 23 05:10 PM
Jones James	Director	Dec 16	Buy	2.22	40	89	26,014	Dec 23 05:11 PM
Young Caroline	Director	Dec 16	Buy	2.22	20	44	19,448	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 15	Buy	2.24	144	323	203,529	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 15	Buy	2.24	60	134	56,626	Dec 23 05:10 PM
Jones James	Director	Dec 15	Buy	2.24	20	45	25,974	Dec 23 05:11 PM
Young Caroline	Director	Dec 15	Buy	2.24	20	45	19,428	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 14	Buy	2.21	320	707	203,385	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 14	Buy	2.21	120	265	56,566	Dec 23 05:10 PM
Jones James	Director	Dec 14	Buy	2.21	40	88	25,954	Dec 23 05:11 PM
Young Caroline	Director	Dec 14	Buy	2.21	20	44	19,408	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 13	Buy	2.18	320	698	203,065	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 13	Buy	2.18	120	262	56,446	Dec 23 05:10 PM
Jones James	Director	Dec 13	Buy	2.18	40	87	25,914	Dec 23 05:11 PM
Young Caroline	Director	Dec 13	Buy	2.18	20	44	19,388	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 12	Buy	2.14	105	225	202,745	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 12	Buy	2.14	65	139	56,326	Dec 23 05:10 PM
Jones James	Director	Dec 12	Buy	2.14	31	66	25,874	Dec 23 05:11 PM
Young Caroline	Director	Dec 12	Buy	2.14	20	43	19,368	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 09	Buy	2.15	105	226	202,640	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 09	Buy	2.15	65	140	56,261	Dec 23 05:10 PM
Jones James	Director	Dec 09	Buy	2.15	31	67	25,843	Dec 23 05:11 PM
Young Caroline	Director	Dec 09	Buy	2.15	20	43	19,348	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 08	Buy	2.19	105	230	202,535	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 08	Buy	2.19	65	142	56,196	Dec 23 05:10 PM
Jones James	Director	Dec 08	Buy	2.19	31	68	25,812	Dec 23 05:11 PM
Young Caroline	Director	Dec 08	Buy	2.19	20	44	19,328	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 07	Buy	2.18	105	229	202,430	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 07	Buy	2.18	65	142	56,131	Dec 23 05:10 PM
Jones James	Director	Dec 07	Buy	2.18	31	68	25,781	Dec 23 05:11 PM
Young Caroline	Director	Dec 07	Buy	2.18	20	44	19,308	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 06	Buy	2.19	105	230	202,325	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 06	Buy	2.19	65	142	56,066	Dec 23 05:10 PM
Jones James	Director	Dec 06	Buy	2.19	31	68	25,750	Dec 23 05:11 PM
Young Caroline	Director	Dec 06	Buy	2.19	20	44	19,288	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 05	Buy	2.19	105	230	202,220	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 05	Buy	2.19	65	142	56,001	Dec 23 05:10 PM
Jones James	Director	Dec 05	Buy	2.19	31	68	25,719	Dec 23 05:11 PM
Young Caroline	Director	Dec 05	Buy	2.19	20	44	19,268	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 02	Buy	2.31	105	243	202,115	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 02	Buy	2.31	65	150	55,936	Dec 23 05:10 PM
Jones James	Director	Dec 02	Buy	2.31	31	72	25,688	Dec 23 05:11 PM
Young Caroline	Director	Dec 02	Buy	2.31	20	46	19,248	Dec 23 05:13 PM
Krogulski Kenneth	Director	Dec 01	Buy	2.33	105	245	202,010	Dec 23 05:07 PM
Galante Joseph C	Director	Dec 01	Buy	2.33	65	151	55,871	Dec 23 05:10 PM
Jones James	Director	Dec 01	Buy	2.33	31	72	25,657	Dec 23 05:11 PM
Young Caroline	Director	Dec 01	Buy	2.33	20	47	19,228	Dec 23 05:13 PM
Krogulski Kenneth	Director	Nov 30	Buy	2.32	105	244	201,905	Dec 23 05:01 PM
Galante Joseph C	Director	Nov 30	Buy	2.32	65	151	55,806	Dec 23 05:03 PM
Jones James	Director	Nov 30	Buy	2.32	31	72	25,626	Dec 23 05:04 PM
Young Caroline	Director	Nov 30	Buy	2.32	20	46	19,208	Dec 23 05:05 PM
Krogulski Kenneth	Director	Nov 29	Buy	2.34	105	246	201,800	Dec 23 05:01 PM
Galante Joseph C	Director	Nov 29	Buy	2.34	65	152	55,741	Dec 23 05:03 PM
Jones James	Director	Nov 29	Buy	2.34	31	73	25,595	Dec 23 05:04 PM
Young Caroline	Director	Nov 29	Buy	2.34	20	47	19,188	Dec 23 05:05 PM
Krogulski Kenneth	Director	Nov 28	Buy	2.37	105	249	201,695	Dec 23 05:01 PM
Galante Joseph C	Director	Nov 28	Buy	2.37	65	154	55,676	Dec 23 05:03 PM
Jones James	Director	Nov 28	Buy	2.37	31	73	25,564	Dec 23 05:04 PM
Young Caroline	Director	Nov 28	Buy	2.37	20	47	19,168	Dec 23 05:05 PM
Krogulski Kenneth	Director	Nov 25	Buy	2.31	105	243	201,590	Dec 23 05:01 PM
Galante Joseph C	Director	Nov 25	Buy	2.31	65	150	55,611	Dec 23 05:03 PM
Jones James	Director	Nov 25	Buy	2.31	31	72	25,533	Dec 23 05:04 PM
Young Caroline	Director	Nov 25	Buy	2.31	20	46	19,148	Dec 23 05:05 PM
Krogulski Kenneth	Director	Nov 23	Buy	2.29	105	240	201,485	Dec 23 05:01 PM
Galante Joseph C	Director	Nov 23	Buy	2.29	65	149	55,546	Dec 23 05:03 PM
Jones James	Director	Nov 23	Buy	2.29	31	71	25,502	Dec 23 05:04 PM
Young Caroline	Director	Nov 23	Buy	2.29	20	46	19,128	Dec 23 05:05 PM
Krogulski Kenneth	Director	Nov 22	Buy	2.37	105	249	201,380	Dec 23 05:01 PM
Galante Joseph C	Director	Nov 22	Buy	2.37	65	154	55,481	Dec 23 05:03 PM
Jones James	Director	Nov 22	Buy	2.37	31	73	25,471	Dec 23 05:04 PM
Young Caroline	Director	Nov 22	Buy	2.37	20	47	19,108	Dec 23 05:05 PM
Krogulski Kenneth	Director	Nov 21	Buy	2.38	105	250	201,275	Dec 23 05:01 PM
Galante Joseph C	Director	Nov 21	Buy	2.38	65	155	55,416	Dec 23 05:03 PM
Jones James	Director	Nov 21	Buy	2.38	31	74	25,440	Dec 23 05:04 PM
Young Caroline	Director	Nov 21	Buy	2.38	20	48	19,088	Dec 23 05:05 PM
Krogulski Kenneth	Director	Nov 18	Buy	2.27	105	238	201,170	Dec 23 05:01 PM
Galante Joseph C	Director	Nov 18	Buy	2.27	65	148	55,351	Dec 23 05:03 PM
Jones James	Director	Nov 18	Buy	2.27	31	70	25,409	Dec 23 05:04 PM
Young Caroline	Director	Nov 18	Buy	2.27	20	45	19,068	Dec 23 05:05 PM
Krogulski Kenneth	Director	Nov 17	Buy	2.29	105	240	201,065	Dec 23 05:01 PM
Galante Joseph C	Director	Nov 17	Buy	2.29	65	149	55,286	Dec 23 05:03 PM
Jones James	Director	Nov 17	Buy	2.29	31	71	25,378	Dec 23 05:04 PM
Young Caroline	Director	Nov 17	Buy	2.29	20	46	19,048	Dec 23 05:05 PM
Krogulski Kenneth	Director	Nov 16	Buy	2.31	105	243	200,960	Dec 23 05:01 PM
Galante Joseph C	Director	Nov 16	Buy	2.31	65	150	55,221	Dec 23 05:03 PM
Jones James	Director	Nov 16	Buy	2.31	31	72	25,347	Dec 23 05:04 PM
Young Caroline	Director	Nov 16	Buy	2.31	20	46	19,028	Dec 23 05:05 PM
Krogulski Kenneth	Director	Nov 15	Buy	2.35	105	247	200,855	Dec 23 05:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CPIX | Cumberland Pharmaceuticals Inc.

Upgrade your FINVIZ experience